Release: DEADLINE ALERT Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Portola Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Release

DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Portola Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

11 March 2020

Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of investors that purchased Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) securities between January 8, 2019 and February 26, 2020 (the “Class Period”). Investors have until March 16, 2020 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Read full release.

Release: SHAREHOLDER ALERT Pawar Law Group Announces a Securities Class Action Lawsuit Against Portola Pharmaceuticals, Inc.– PTLA

Release

SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Portola Pharmaceuticals, Inc.– PTLA

27 January 2020

Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Portola Pharmaceuticals, Inc. (PTLA) from November 5, 2019 through January 9, 2020, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Portola Pharmaceuticals, Inc. investors under the federal securities laws.

Read full release.